135 related articles for article (PubMed ID: 2988839)
21. Converting enzyme inhibition during chronic angiotensin II infusion in rats: evidence against a non-angiotensin mechanism.
Textor SC; Brunner HR; Gavras H
Clin Sci (Lond); 1980 Dec; 59 Suppl 6():71s-74s. PubMed ID: 6256120
[TBL] [Abstract][Full Text] [Related]
22. Chronic ouabain infusion does not cause hypertension in sheep.
Pidgeon GB; Richards AM; Nicholls MG; Charles CJ; Rademaker MT; Lynn KL; Bailey RR; Lewis LK; Yandle TG
Am J Physiol; 1996 Mar; 270(3 Pt 1):E386-92. PubMed ID: 8638682
[TBL] [Abstract][Full Text] [Related]
23. Effects of captopril and enalapril on sodium excretion and blood pressure in sodium-deficient dogs.
McCaa RE; Gillespie JB
Fed Proc; 1984 Apr; 43(5):1336-41. PubMed ID: 6323226
[TBL] [Abstract][Full Text] [Related]
24. Effect of 12-hour infusions of saralasin or captopril on blood pressure in hypertensive conscious rats. Relationship to plasma renin, duration of hypertension, and effect of unclipping.
Bing RF; Russell GI; Swales JD; Thurston H
J Lab Clin Med; 1981 Aug; 98(2):302-10. PubMed ID: 7019368
[TBL] [Abstract][Full Text] [Related]
25. Progesterone antagonizes development but not maintenance of ACTH-induced hypertension in sheep.
Spence CD; Reid AF; Coghlan JP; Mills EH; Whitworth JA; Scoggins BA
Clin Exp Pharmacol Physiol; 1989 Aug; 16(8):659-69. PubMed ID: 2551550
[TBL] [Abstract][Full Text] [Related]
26. Captopril prevents chronic hypertension produced by infusion of endothelin-1 in rats.
Mortensen LH; Fink GD
Hypertension; 1992 Jun; 19(6 Pt 2):676-80. PubMed ID: 1592467
[TBL] [Abstract][Full Text] [Related]
27. Captopril in clinical hypertension. Changes in components of renin-angiotensin system and in body composition in relation to fall in blood pressure with a note on measurement of angiotensin II during converting enzyme inhibition.
Atkinson AB; Morton JJ; Brown JJ; Davies DL; Fraser R; Kelly P; Leckie B; Lever AF; Robertson JI
Br Heart J; 1980 Sep; 44(3):290-6. PubMed ID: 7000102
[TBL] [Abstract][Full Text] [Related]
28. Participation of the renin-angiotensin system in the maintenance of blood pressure during changes in posture in patients with essential hypertension.
Morganti A; Sala C; Turolo L; Palermo A; Zanchetti A
J Hypertens; 1985 Feb; 3(1):55-61. PubMed ID: 2987342
[TBL] [Abstract][Full Text] [Related]
29. Converting enzyme inhibition in mild and moderate essential hypertension. II.
Rasmussen S; Leth A; Ibsen H; Damkjaer Nielsen M; Nielsen F; Giese J
Acta Med Scand; 1986; 219(1):29-36. PubMed ID: 3006449
[TBL] [Abstract][Full Text] [Related]
30. Blunted renal responses to angiotensin II infusion in lifetime captopril-treated spontaneously hypertensive rats.
Wu JN; Tsai SY; Hsieh WY
Chin J Physiol; 2001 Jun; 44(2):59-65. PubMed ID: 11530945
[TBL] [Abstract][Full Text] [Related]
31. Effects of captopril, an angiotensin-converting enzyme inhibitor, in normotensive sodium-replete volunteers.
Shepherd AN; Campbell BC; Reid JL
J Cardiovasc Pharmacol; 1982; 4(3):381-7. PubMed ID: 6177933
[TBL] [Abstract][Full Text] [Related]
32. Amiloride blocks the onset of ACTH-induced hypertension in the sheep.
Reid AF; Coghlan JP; Whitworth JA; Scoggins BA
Am J Hypertens; 1990 Oct; 3(10):775-81. PubMed ID: 2171563
[TBL] [Abstract][Full Text] [Related]
33. Effects of angiotensin I converting enzyme inhibition and calcium channel blockade on plasma levels of active and inactive renin in conscious rabbits.
Eisen V; Munday MR; Slater JD
Biochem Pharmacol; 1987 Jul; 36(14):2331-5. PubMed ID: 2440439
[TBL] [Abstract][Full Text] [Related]
34. Effects of captopril on the renin angiotensin system, oxidative stress, and endothelin in normal and hypertensive rats.
Bolterman RJ; Manriquez MC; Ortiz Ruiz MC; Juncos LA; Romero JC
Hypertension; 2005 Oct; 46(4):943-7. PubMed ID: 16087785
[TBL] [Abstract][Full Text] [Related]
35. Significance of kallikrein-kinin and renin-angiotensin systems in the hypotensive mechanism of angiotensin-I converting enzyme inhibitors in essential hypertensives.
Iimura O; Shimamoto K
Adv Exp Med Biol; 1989; 247A():39-48. PubMed ID: 2532450
[TBL] [Abstract][Full Text] [Related]
36. Converting enzyme inhibition and modulation of plasma renin activity with captopril in anesthetized rats.
Suzuki M; Satoh S
Arch Int Pharmacodyn Ther; 1981 Sep; 253(1):121-36. PubMed ID: 6275810
[TBL] [Abstract][Full Text] [Related]
37. Intra-cerebroventricular captopril reduces plasma ACTH and vasopressin responses to hemorrhagic stress.
Cameron VA; Espiner EA; Nicholls MG; MacFarlane MR; Sadler WA
Life Sci; 1986 Feb; 38(6):553-9. PubMed ID: 3003485
[TBL] [Abstract][Full Text] [Related]
38. Cardiovascular regulation during angiotensin converting enzyme inhibition with captopril in diabetes-associated hypertension.
Beretta-Piccoli C; Ziegler WH; Antonini P; Bernasconi-Zapf M; Kressebuch H; Pianezzi F
J Hypertens; 1990 Jul; 8(7):671-8. PubMed ID: 2168458
[TBL] [Abstract][Full Text] [Related]
39. Adrenocorticotrophin-induced hypertension in rats. Role of progesterone and digoxin-like substances.
Li M; Wong KS; Martin A; Whitworth JA
Am J Hypertens; 1994 Jan; 7(1):59-68. PubMed ID: 8136112
[TBL] [Abstract][Full Text] [Related]
40. Effects of angiotensin I converting enzyme inhibitor (SQ 14225) on control of aldosterone.
Eguchi T; Saito I; Nakamura R; Yasui T; Saruta T
Acta Endocrinol (Copenh); 1980 Jun; 94(2):213-20. PubMed ID: 6251687
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
